[1] Chacko K R, Wolkoff A W. Intrahepatic cholestasis of pregnancy: new diagnostic insights. Ann Hepatol, 2017, 16:176-178. [2] 徐红娟, 卞晓云, 陈晓熹, 等.孕妇外周血NKT细胞水平与妊娠期肝内胆汁淤积症发病及病情关系.中国计划生育学杂志,2021, 29:71-74. [3] Kulhan M, Kulhan N G, Nayki U, et al. Intrahepatic cholestasis of pregnancy and fetal outcomes. mini review. Arch Med Sci, 2017, 2:85-86. [4] Yilmaz Z V, Turkmen G G, Daglar K, et al. Elevated red blood cell distribution width is associated with intrahepatic cholestasis of pregnancy. Ginekol Pol, 2017, 88:75-80. [5] Wijarnpreecha K, Thongprayoon C, Sanguankeo A, et al. Hepatitis c infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol, 2017, 41:39-45. [6] 中华医学会妇产科学分会产科学组. 妊娠期肝内胆汁淤积症诊疗指南(2015). 中华妇产科杂志,2015, 50:481-485. [7] 乔娟, 漆洪波. 胎儿生长受限:更新的认识. 中华围产医学杂志, 2015, 18:418-420. [8] Yayla A, Cigdem V F, Kιlιccι C, et al. Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?. Turk J Obstet Gynecol, 2017, 14:160-165. [9] Koroglu N, Tayyar A, Tola E N, et al. Increased levels of the novel hepatokine fetuin b in patients with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med, 2019, 32:1620-1625. [10] Kremer A E, Wolf K, Stánder S. Intrahepatic cholestasis of pregnancy : rare but important. Hautarzt, 2017, 68:95-102. [11] 何一帆, 邵勇, 胥飚, 等. 血清胆汁酸代谢轮廓分析用于妊娠期肝内胆汁淤积症的早期诊断. 重庆医科大学学报, 2018, 43:1458-1463. [12] 杨杰莲, 刘敏. ICP与妊娠期CHB伴胆汁酸升高的围产结局比较. 现代妇产科进展, 2017, 26:760-762. [13] 王艳清, 杨潇, 鲜舒. 胎盘胆汁酸转运体及核受体与妊娠期肝内胆汁酸淤积症. 现代妇产科进展, 2017, 26:937-939. [14] 文香, 胡章雪, 廖莉. 妊娠期肝内胆汁淤积症血清总胆汁酸与新生儿肺损伤程度的相关性. 重庆医学, 2017, 46:2621-2623. [15] 肖凤莲, 郑英如. 妊娠期肝内胆汁淤积症总胆汁酸水平及终止妊娠时间与围产儿结局的关系. 第三军医大学学报, 2018, 40:90-94. [16] 姚雪梅, 丁桂凤. 产妇高龄对妊娠合并症及妊娠结局影响的研究. 实用预防医学, 2017, 24:1200-1204. [17] 詹爱丁, 蒋国洪, 孔成才. 妊娠期肝内胆汁淤积症合并妊娠期高血压疾病及妊娠期糖尿病对妊娠结局的影响. 中国妇幼保健, 2019, 34:4138-4141. [18] 张建华, 李秀华. 胎盘胆汁酸转运体及核受体与妊娠期肝内胆汁淤积症的研究进展. 中国生育健康杂志, 2020, 31:87-89. |